X-energy

Phase A — Understand the business

Lens 1 · Company Overview

X-energy is a vertically-integrated advanced-nuclear developer with two products that only work together: the Xe-100 reactor and TRISO-X fuel. Founded 2009 by Kam Ghaffarian; HQ Rockville, Maryland; ~1,000+ employees; public since 2026-04-24 (Nasdaq: XE).

• The reactor (Xe-100): an 80 MWe / 200 MWth high-temperature gas-cooled reactor (HTGR) using a pebble-bed core — ~220,000 graphite "pebbles," each holding ~19,000 TRISO fuel particles, cooled by inert helium exiting at >750°C. Sold as a "four-pack" = 320 MWe / 800 MWth standard plant. The high-temperature helium output is the commercial hook: it can drive electricity and deliver industrial process steam/heat, which is why the lead customer is a chemical plant, not a utility.
• The fuel (TRISO-X): X-energy manufactures its own proprietary TRISO fuel through wholly-owned TRISO-X, LLC. TRISO particles encapsulate a HALEU (≈20%-enriched uranium) kernel in ceramic/graphite layers engineered to contain fission products up to ~1,800°C — the basis of the "meltdown-proof / walk-away safe" claim (if temperature rises, the reaction self-quenches).
• How it makes money today: almost entirely U.S. government cost-share. Q1-2026 total revenue + grant income was $43.4M, of which the DOE contributed ~$39M (~90%) under the Advanced Reactor Demonstration Program (ARDP). There is no commercial reactor revenue yet — first commercial power is early-2030s.
• The commercial pipeline (contracted intent, not revenue): Dow (4 units, Texas), Amazon/Energy Northwest (up to 12 units / 960 MW, Washington), Centrica (up to 12 units, UK Hartlepool), plus Amazon's framework option for >5 GW of Xe-100 by 2039.

Contract structure: the near-term "revenue" is a cost-plus/milestone government cooperative agreement (ARDP — see Lens 5), not take-or-pay commercial offtake. The customer agreements (Dow "Long Mott Energy," Amazon/Energy Northwest "Cascade," Centrica) are development/funding frameworks and options, not firm fixed-price reactor orders that have converted to backlog. This is the single most important thing to understand about the P&L: it is a grant-funded R&D company wearing a commercial-order narrative.

Lens 2 · Supply Chain

Map: enriched-uranium feedstock → fuel fabrication → reactor components → EPC → industrial/utility/hyperscaler offtaker. X-energy owns the middle (fuel + reactor design/integration) and is exposed at both ends.

• Upstream chokepoint #1 — HALEU (the binding constraint). The Xe-100 needs High-Assay Low-Enriched Uranium (~20% enriched). Until recently Russia (Rosatom/Tenex) held a near-monopoly on commercial HALEU; the U.S. supply is only now being stood up. The domestic anchor is Centrus Energy (LEU) — Piketon, Ohio — which signed a $900M fixed-price DOE HALEU award on 2026-07-01 to scale to ~12 MT/yr, alongside Urenco USA, Orano USA and General Matter (Oct-2024 DOE awards). HALEU availability is the sector's central constraint and X-energy's most acute single-source dependency: TRISO-X fabricates the fuel form, but cannot make the enriched feedstock.
• Midstream — fuel fabrication (owned, and a genuine differentiator). TRISO-X's TX-1 facility at Oak Ridge, TN is the first NRC Category-II special-nuclear-material license ever issued (Feb 2026) and the first new U.S. fuel facility in >50 years. Above-ground construction began Nov 2025 (Clark Construction, $48.2M core-and-shell); ~214,812 sq ft; capacity ~5 MTU / 700,000 pebbles per year → enough for ~11 Xe-100s; operations ~2027. A planned TX-2 would add ~20 MTU/yr (≈144 reactors). Combined TX-1+TX-2 build cost ~$768M over five years.
• Midstream — reactor components. Curtiss-Wright (2022) supplies three critical Xe-100 components (reactor-protection/instrumentation & control class). Graphite, helium-circulation, and pressure-vessel supply chains for HTGRs are thin and largely non-U.S. — a NOAK-scaling risk not yet stress-tested at volume.
• EPC / site delivery. Dow's subsidiary Long Mott Energy is the licensee/builder for the Texas plant; Energy Northwest (public utility) is the operator for the Washington "Cascade" project. X-energy is the reactor/fuel supplier and integrator, not the balance-sheet owner of the plants — capital-light on paper, but it also means it does not capture the plant economics, only the reactor + fuel + services.
• Downstream offtakers (named): Dow (Seadrift/UCC industrial steam + power), Amazon (data-center power via Energy Northwest), Centrica (UK). Concentration is extreme on two anchor names (Amazon, Dow) plus the U.S. government.

Verdict on the chain: owning fuel fabrication is the real structural asset (nobody else in the U.S. is building commercial TRISO at scale). But the chain has a hard upstream gate (HALEU) X-energy does not control, and a thin, non-commercialized component base for NOAK scaling. Names present; chokepoints real.

Lens 3 · Competitive Advantages (moats)

Four candidate moats, graded:

1. Vertical fuel integration (STRONG, and the best one). TRISO-X/TX-1 is the only U.S. commercial-scale advanced-fuel line under construction with an NRC Cat-II license in hand. Advanced reactors are fuel-gated; owning the only domestic TRISO line is a genuine switching/scarcity moat — and a potential merchant fuel business (selling TRISO to other HTGR/pebble developers).
2. Customer roster / demand pre-emption (STRONG for optics, UNPROVEN for economics). Amazon (equity + >5 GW option), Dow, Energy Northwest, Centrica is arguably the best offtake roster in the SMR field. It is a real distribution advantage — but until an order converts to a firm, priced, financed plant, it is a moat around attention, not around cash flow.
3. Regulatory navigation (MODERATE-STRONG). A CEO who was U.S. Deputy Secretary of Energy (Lens 9) and first-mover licensing artifacts (first Cat-II fuel license; Dow FONSI/EA completed ahead of schedule; UK GDA entry) are a durable process advantage in an industry where the regulator is the gate.
4. Design/IP (CONTESTED). Pebble-bed HTGR + TRISO is not proprietary to X-energy — it descends from German AVR/THTR and Chinese HTR-PM (the only operating pebble-bed reactor, in China). The specific Xe-100 integration and TRISO-X recipe are proprietary; the architecture is not. This is weaker than bulls imply.

Bargaining power: weak vs. HALEU suppliers (X-energy needs Centrus more than Centrus needs any one reactor developer near-term), weak vs. the NRC (regulator holds the gate), moderate vs. customers (Amazon/Dow have optionality across SMR vendors — Amazon also backs other nuclear plays; Google backs Kairos). Net: the moat is real on fuel, thin on reactor architecture, and unmonetized on customers.

Lens 4 · Segments

No commercial product segments exist yet — the "segments" are program lines, all effectively one revenue source. segments.csv is header-only / empty, so this is ``:

• Reactor development (Xe-100) — funded by DOE ARDP + Dow/Amazon/Centrica development agreements.
• Fuel (TRISO-X / TX-1/TX-2) — the intended future product/merchant line; pre-revenue on commercial sales.
• Revenue by source (the only meaningful "segmentation"): Q1-2026 total revenue+grants $43.4M, DOE ~$39M (~90%); the remainder customer-development work.
• Geography: ~all U.S. today (DOE); future geographic optionality via UK (Centrica/Hartlepool, GDA) and prior international interest (Canada/Jordan-era MOUs, not material).

Trend: revenue is accelerating off a government base (Q1-2026 +109% YoY) — but that is program spend, not commercial traction; more DOE-funded activity mechanically lifts "revenue" while losses widen. Do not read the top-line growth as demand.

---

Phase B — Measure performance

(+private overlay: Lens 5 → funding & valuation trajectory; Lens 7 → cap table & post-IPO marks. Both now blended with the newly-public financials.)

Lens 5 · Funding & Valuation Trajectory (overlay lens — replaces "Earnings Result"; newly-public financials folded in)

The capital story, seed → public:

• 2016 — DOE Advanced Reactor Concept award, up to $40M (5 yr).
• Oct 2020 — DOE ARDP selection: $80M initial, total up to ~$1.2–1.23B federal cost-share over 7 yrs to design/license/build/demonstrate Xe-100 + a commercial TRISO facility by ~end of decade. This is the spine of the whole P&L.
• Dec 2022 — announced a ~$2B SPAC via Ares Acquisition Corp (AAC) → terminated Oct/Nov 2023 (SPAC window collapsed). A prior de-SPAC failure is a material history item.
• Dec 2023 — Series C $235M from existing investors (bridge after SPAC fell through).
• Oct 2024 — Amazon-led strategic round ~$500M (part of a ~$700M raise), plus Amazon's >5 GW-by-2039 framework.
• Nov 2025 — $700M oversubscribed Series D.
• Apr 2026 — IPO (the capstone). Priced $23/share, upsized (above the $16–19 range), base 44.25M Class A shares (~42.9M in an earlier S-1/A), closed ~50.9M shares incl. greenshoe → ~$1.02B gross / ~$1.1B net proceeds; billed the largest nuclear IPO on record. Underwriters lifted the deal on strong demand.
• Valuation at pricing: ~$9.12B market cap; first-day close $29.20 (+27%), intraday to ~$30.11 open, later 52-wk high $37.10 → implied ~$11.5B peak.

Newly-public financials (all ``, secondary-sourced):

• Q1-2026 expense stack: direct program costs $65.4M, SG&A $44.1M, formal R&D line only $55K (R&D is expensed inside direct program costs). Net loss $166.2M >> op burn $67.3M ⇒ ~$99M non-cash / one-time (IPO-related, SBC, and pre-IPO instrument remeasurement — flag in Lens 10).
• Balance sheet (the bull's best card): cash + investments $944M at 3/31/26 (incl. ~$720M held-to-maturity) + ~$1.1B net IPO ⇒ ~$2.05B pro-forma liquidity, no debt. At ~$200–270M/yr burn and rising, that is multiple years of runway — enough to reach the Dow CPA and early NOAK milestones without a raise.
• Watch item: a Tax Receivable Agreement (TRA) with legacy holders will divert future cash to pre-IPO owners (Lens 10).

Read: the funding trajectory is a success — X-energy out-raised every SMR peer and reached the public market with a fortress balance sheet. The operating result underneath it is a widening loss on ~90%-government revenue with zero commercial sales.

Lens 6 · Management Narrative / "Calls" (sentiment) (overlay: founder/exec interviews + the single public earnings call)

Only one public reporting cycle exists (Q1-2026, the debut quarter), so a multi-call sentiment trend isn't yet available — flag and carry forward. What the record shows:

• Consistent message discipline: "first advanced reactor + fuel by end of decade," "walk-away safe," "vertically integrated fuel," "demand from data centers + industrial heat." The narrative has been stable across 2020→2026 — a positive (no strategy drift).
• Debut-quarter tone (Q1-2026): management leaned on "+109% revenue growth" and "$2B+ liquidity, no debt"; the market instead fixated on "heavy cash burn and post-IPO valuation" — the stock slid despite the beat-shaped headline. The gap between management's growth framing and the tape's burn framing is the sentiment signal.
• Founder voice (Ghaffarian): frames X-energy inside a portfolio of capital-intensive moonshots (Intuitive Machines/LUNR, Axiom, Quantum Space). Visionary and credible on ambition; the pattern also means promotional, milestone-driven communication — weigh accordingly (Lens 9/13).

Lens 7 · Cap Table & Peer Marks (overlay lens — replaces "Comps")

Cap table (post-IPO, dual-class, founder-controlled):

• Kam Ghaffarian (founder, via IBX) — controls ~61% of Class B super-voting stock ⇒ effective voting control of a public company.
• Ares Management affiliates — ~26% (legacy from the collapsed AAC SPAC sponsor relationship, rolled into equity).
• Amazon — ~13.4% post-IPO (down from a reported ~29% pre-IPO on dilution). A crossover-strategic of the highest quality — but note it is a customer-investor, aligned to cheap power, not necessarily to XE equity upside.
• ~406.4M total shares outstanding (Class A + B).

Public SMR peer marks (multiples `` or n/a; never fabricated):

• Multiple check (``): XE at ~$6.24B mcap on ~$94–117M revenue = ~53–66× P/S; net of ~$2.05B pro-forma cash, EV ≈ ~$4.2B ⇒ ~36–45× EV/Sales — on revenue that is 90% government grant. Oklo trades richer on market cap ($12.9B) with no revenue at all; the whole cohort is valued on optionality, not fundamentals. There is no P/E, no dividend, no positive ROE anywhere in the peer set — classic pre-commercial thematic basket.
• Relative positioning: on regulatory progress, X-energy lags Kairos, TerraPower and NuScale (all hold construction permits or a design approval; X-energy holds neither for the reactor) but leads on fuel (only one with a licensed commercial TRISO line) and arguably leads on customer quality (Amazon + Dow).

Lens 8 · Stock-Price Catalysts

Only ~11 weeks of tape (IPO 2026-04-24 → 2026-07-10), but the moves are instructive:

• 2026-04-24 — IPO/debut: priced $23 (upsized), +27% to $29.20 — euphoria; AI-power + "largest nuclear IPO" narrative.
• → 52-wk high $37.10 shortly after debut (momentum/lock-up-free float squeeze).
• Q1-2026 print / post-IPO digestion: stock slides on "heavy cash burn + valuation" despite +109% revenue.
• 2026-07-01 — analyst re-rate: UBS keeps Buy but cuts PT $40→$34; Jefferies Hold, cuts PT $30→$22 on valuation.
• 2026-07-10 — $15.35, −7.5% on day, at 52-wk LOW — below the $23 IPO price and below even Jefferies' bearish $22 target; −33% from IPO, −59% from the $37 high.
• Consensus: "Buy," avg PT $39.86 (8 analysts, S&P Global) — i.e. Street targets sit ~2.5× the current price, a wide, unresolved bull/bear gap. Days-to-cover 1.8 (liquid, not a short squeeze setup).

What the tape reveals: this name trades on narrative and rate/AI-power sentiment, not fundamentals (there are none yet). The pattern — euphoric IPO → burn-and-valuation reality → 52-wk low with Street targets stranded far above — is a textbook post-IPO de-rating of a pre-commercial story. The next fundamental catalyst (Dow CPA) is ~2 quarters out; until then it's a sentiment/burn stock.

---

Phase C — Judge people & books

Lens 9 · Management

• J. Clay Sell — CEO (since Jan 2019). The defining hire: former U.S. Deputy Secretary of Energy (COO of the DOE) under G.W. Bush (2005-08); prior Senate Energy & Water Appropriations clerk under Sen. Domenici; White House economic/legislative aide; later President of Hunt Energy Horizons. This is the ultimate regulatory/appropriations insider running a company whose entire value depends on the NRC and DOE. Track record: he has steered X-energy through the ARDP award, the first Cat-II fuel license, the Dow FONSI-ahead-of-schedule, a $700M Series D and the largest nuclear IPO on record. Strong, on-archetype execution.
• Kam Ghaffarian — Founder & Executive Chairman (controls ~61% Class B). Serial deep-tech founder: built SGT (govt services, sold to KBR ~$355M), and co-founded Intuitive Machines (Nasdaq: LUNR), Axiom Space, Quantum Space, and IBX (his investment vehicle, the top XE holder). Visionary, capital-savvy, genuinely credible on hard-tech. Caveats: (a) founder super-voting control of a public company concentrates governance risk; (b) his other public vehicle, Intuitive Machines, has been a volatile, milestone-slipping, loss-making stock with failed/partial lunar landings — a fair cautionary read on how a Ghaffarian moonshot behaves once public; (c) his portfolio breadth raises attention/related-party questions (IBX).
• Capital allocation: pre-commercial, so no buyback/M&A/ROIC record to judge. What we can judge — fundraising — is best-in-class (out-raised the field, IPO'd with a fortress balance sheet, no debt). The forward test is discipline on a $200M+/yr burn over a 5-7-year pre-revenue desert.
• Archetype: founder-controlled, government-anchored deep-tech — high ceiling, high governance/dilution risk, milestone-driven communication. Weight promises against the SMR industry's universal record of slippage.

Lens 10 · Forensic Red Flags

All figures `` (no filings on disk; EDGAR 403). Flags to verify against the S-1/10-Q when the fetch path opens:

1. Revenue quality — ~90% is government grant/cost-share, not commercial sales. "Revenue+grant income" blends DOE ARDP reimbursement with customer-development work. Reported "+109% growth" is program-spend growth. The company has no commercial reactor or fuel revenue. This is the headline accounting-substance flag: top-line optics overstate commercial traction.
2. Net loss >> cash burn (non-cash tail). Q1-2026 net loss $166.2M vs operating burn $67.3M → ~$99M non-cash/one-time. The FY2024→FY2025 net loss jump ($126M→$390M) similarly outran operating growth — consistent with fair-value remeasurement of pre-IPO convertible/warrant instruments + heavy SBC. Non-GAAP framing will flatter this; insist on cash burn and dilution as the real gauges.
3. Tax Receivable Agreement (TRA). Prospectus discloses a TRA that diverts a share of future tax benefits as cash to legacy/pre-IPO holders — a structural, related-party cash leakage common to Up-C IPOs. Quantify from the S-1.
4. Dual-class super-voting control (Ghaffarian ~61% of Class B). Public shareholders have minimal governance leverage; approval of related-party dealings (e.g., with IBX/other Ghaffarian ventures) sits with the founder. Watch related-party notes.
5. Going-concern / runway: not a going-concern flag today (~$2.05B liquidity, no debt) — but the entire model is "raise now, burn for 5-7 years, hope offtake converts." Any schedule slip compounds the burn before a single commercial dollar arrives.
6. Capitalized vs. expensed costs (verify): as TX-1 construction ramps, watch whether facility/dev costs are capitalized in ways that defer expense recognition. Not yet sourced — a real S-1 read item.

Regulatory findings (required):

• SEC enforcement (EDGAR LR/AAER): — none. File notes X-energy had "no CIK — private" at Stage 1; the EFTS LR/AAER search returned 0 findings. (Now that XE is public with CIK 0002088896, a future run should re-scan EDGAR enforcement, but as a company public <3 months there is no plausible enforcement history.)
• Non-SEC (FTC/DOJ/FDA/NRC/etc.): web search surfaced no enforcement actions, consent decrees, fines or penalties against X-energy. The relevant "regulatory" facts are licensing, not enforcement: first NRC Cat-II fuel license (Feb 2026, a positive); Xe-100 design licensed nowhere yet; Dow CPA docketed May-2025 with FONSI/EA completed ahead of schedule, CPA expected Q1-2027; UK GDA entry filed.
• 10-K Item 3 (Legal Proceedings): no 10-K exists yet (first annual not due until ~early 2027); no material litigation surfaced in the S-1 coverage.
• Conclusion: No material regulatory or legal enforcement findings — verified via the Stage-1 SEC EDGAR EFTS scan (0 LR/AAER), web search (no FTC/DOJ/NRC actions), and S-1 coverage, as of 2026-07-10. The binding regulatory facts are prospective licensing milestones, not past enforcement.

---

Phase D — Project & stress-test

Lens 11 · Post-IPO Valuation & Path-to-Cash-Flow (overlay lens — "IPO-readiness/path-to-tradeable," now RESOLVED)

The +private Lens 11 question — "what unlocks a tradeable security and when?" — has resolved: XE has been tradeable since 2026-04-24. The forward question flips to "what is it worth, and can it reach commercial cash flow before the money-narrative fades?" No EPS projection is meaningful (deep, widening losses through the early 2030s), so this is a milestone-and-liquidity projection, not an EPS model.

Runway math ``: ~$2.05B pro-forma liquidity, no debt; burn ~$67.3M/qtr and accelerating as TX-1 build + headcount scale → call it ~$300–400M/yr by 2027-28. That funds operations through ~2029-2030 without a raise — i.e. it reaches the Dow CPA (Q1-2027) and early construction, but likely needs additional capital (equity or project finance) to actually build and reach first power in 2031-32. Dilution is a when-not-if.

Value drivers (in order of impact on the equity):

1. Dow Long Mott construction permit (expected Q1-2027) — the first hard de-risking event; turns "design" into "permitted to build."
2. A firm, financed, priced reactor order converting to backlog — the moment the customer roster becomes revenue rather than optionality.
3. HALEU supply secured at commercial scale (Centrus ramp) — removes the fuel gate.
4. TX-1 operational (2027) + TRISO merchant sales — proves the one real moat and could add a second revenue leg.
5. First concrete poured / first fuel loaded (early 2030s) — the terminal proof.

Scenario frame (``, qualitative — precise multiples n/a):

• Base: Dow CPA lands ~2027, first power ~2032, Amazon option partially converts. A pre-commercial developer with a fortress balance sheet re-rates with rates/AI-power sentiment; fair value plausibly mid-$20s–$30s (the Street's $34-40 targets assume execution stays on rail). Wide error bars.
• Bull: CPA on time + a financed Amazon/Dow order + HALEU locked + TRISO merchant demand → the SMR "winner" narrative; the $37 high revisited and beyond as first power nears.
• Bear: CPA slips (as SMR timelines historically do), burn forces a dilutive raise into a soft tape, AI-power hype cools → sub-$15, a multi-year pre-revenue dead-money stretch.

(Per task wave-boundaries: no forecast.ts create in this unattended run. A tracked Brier forecast on "Dow Long Mott construction permit issued by 2027-06-30, p≈0.6" is the natural next binary to log in an interactive pass.)

Lens 12 · Bull vs Bear

Bull case. X-energy is the most commercially-de-risked SMR story by customer quality: Amazon (equity + >5 GW by 2039), Dow (industrial anchor), Energy Northwest, Centrica — a roster no peer matches, aimed squarely at the two demand pools that actually pay up for firm clean power (AI data centers + industrial process heat). It is the only U.S. player that owns commercial TRISO fuel (TX-1 licensed, TX-2 planned) — a scarce, gating asset and a potential merchant business. The Xe-100's pebble-bed/TRISO "walk-away safe" design is uniquely suited to siting next to chemical plants and data centers. It is run by a former Deputy Secretary of Energy and reached the public market with ~$2.05B and no debt — funded through the valley. If SMRs are real and the 2030s power crunch is real, XE has the roster, the fuel and the balance sheet to be a winner.

Bear case (2-3 permanent-impairment risks).

1. It is a pre-commercial R&D company priced like a platform — ~$4.2B EV on ~$100M of ~90%-government revenue, first power 5-7 years out, Xe-100 licensed nowhere. The equity is the schedule; every slip (and SMR schedules slip — Dow already moved 2030→2031-32) permanently compounds burn before revenue.
2. HALEU dependency it doesn't control — no domestic HALEU at scale, no Xe-100; Centrus is still ramping under DOE contract. A single upstream gate can stall the whole plan.
3. Structural burn + dilution + governance — $300M+/yr burn will require another raise to actually build; founder super-voting control and a TRA mean minority holders bear dilution with little leverage.

Pre-mortem (18 months out, thesis broke): The Dow CPA slipped past 2027; Amazon's option stayed an option; a HALEU delivery date pushed right; the company guided to a larger 2027 raise; AI-power euphoria rotated out of pre-revenue nuclear. XE sits in the low teens as a multi-year "prove-it" burn story, Street targets quietly walked from $40 to $20.

Are multiples too high? For a pre-commercial developer, yes on any fundamental basis (36-45× EV/grant-sales) — but the whole cohort trades on optionality (Oklo richer at ~$12.9B with $0 revenue). The question isn't the multiple; it's whether the milestone cadence holds.

Contrarian view (what the market is refusing to see): the crowd argues Oklo vs. NuScale vs. X-energy as if this is a reactor race. The likelier truth: the binding constraint is fuel (HALEU + TRISO), not reactor design — and X-energy is the only one that owns the fuel line. If that's right, X-energy's real option value is as the arms-dealer of the pebble-bed ecosystem, not merely a reactor vendor. The market is mispricing which layer matters.

Lens 13 · Devil's Advocate (short-seller)

Dismantling the bull case:

• The "revenue" is a DOE reimbursement. Strip the ~90% government grant and there is no business — just a cost-plus R&D contract dressed as commercial growth. "+109%" is spending more of the taxpayer's money faster.
• Customer "orders" are options, not contracts. Amazon's ">5 GW by 2039" is a framework with options; Dow owns the plant and can walk; Amazon simultaneously backs other nuclear and is aligned to cheap power, not XE's stock. None of it is firm, financed, priced backlog. Concentrate risk: if Amazon or Dow blinks, the whole narrative deflates.
• The moat bulls love (fuel) has an upstream master (HALEU). X-energy makes the pebble but can't enrich the uranium — Centrus/DOE hold that gate, and it's Russia-exposed historically. A fuel "moat" with a single-source feedstock is a hostage, not a fortress.
• The design is licensed nowhere and the schedule only moves one way. Kairos and TerraPower already hold construction permits; X-energy's first isn't due until Q1-2027 and first power has already slipped to 2031-32. Nuclear timelines are the most-slipped in industrials.
• Governance is founder-owned; the founder's other public vehicle (LUNR) is a milestone-missing, loss-making, volatile stock. Super-voting control + a TRA + IBX related-party surface = minority holders along for the ride.
• What must hold for today's price: flawless licensing cadence, on-time HALEU, at least one Amazon/Dow option converting to a financed plant, and sustained AI-power sentiment — four independent things, over 5+ years.
• If growth/execution disappoints 20-30% (CPA slips a year, a raise comes early): fair value is low-teens or below — and the tape is already testing that ($15.35, 52-wk low).
• Single permanent-impairment scenario (most plausible): a serious Xe-100 licensing or first-of-a-kind construction setback (NRC delay, a fuel-qualification problem, or a Dow pull-back) that pushes first power past ~2034 — at which point the balance sheet funds survival, not victory, and the equity is a decade of dilution. Plausibility: moderate and rising, given the sector's history.

Lens 14 · Management Questions (ordered by information value)

1. Of your reported revenue, exactly what share is DOE/government cost-share vs. commercial customer payments, and when does the first commercial (non-grant) reactor or fuel dollar arrive?
2. Which of your customer agreements (Dow, Amazon/Energy Northwest, Centrica) is a firm, financed, priced order that will convert to backlog — and on what date — versus an option/framework?
3. What is your secured HALEU supply (volume, supplier, delivery dates) to fuel the first Dow and Cascade units, and what is the plan if Centrus's ramp slips?
4. What is your funded runway to first commercial power, and how much additional capital (equity vs. project finance) will building the first four-pack actually require?
5. Walk through the Dow Long Mott critical path to the Q1-2027 CPA — and the two likeliest reasons it slips.
6. Reconcile the $166M Q1 net loss vs. $67M cash burn: what are the non-cash components, and what is your true steady-state quarterly cash burn through 2028?
7. Quantify the Tax Receivable Agreement: expected cash payments to legacy holders and their drag on shareholder cash over the next decade.
8. What is TX-1's realistic first-fuel date and utilization ramp, and when does TRISO-X become a merchant fuel business selling to third parties?
9. How do you defend against Kairos and TerraPower, who already hold NRC construction permits while the Xe-100 is licensed nowhere?
10. What are the NOAK unit economics (overnight $/kW, LCOE) you're underwriting, and how do they beat gas + CCS or grid+storage for Dow-type customers without subsidy?
11. Given founder super-voting control and IBX, what governance guardrails protect minority holders on related-party transactions?
12. What is the graphite / helium-system / pressure-vessel supply plan for scaling beyond the first four-pack, and where are the single-source risks?
13. How exposed is the model to a change in federal administration or DOE appropriations, given ~90% grant revenue?
14. What Xe-100 fuel-qualification or first-of-a-kind technical milestones remain unproven, and which is the highest-risk?
15. Under what conditions would you slow spend or delay a project to protect the balance sheet, rather than raise dilutive equity into a weak tape?

---